Hubei Biocause Pharmaceutical (000627) — Capital Reinvestment Ratio
Hubei Biocause Pharmaceutical (000627) has a Capital Reinvestment Ratio of 0.04x as of September 2023, meaning it reinvests 0% of its operating cash flow (CN¥276.06 Million) in capital expenditures (CN¥10.51 Million). Check 000627 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hubei Biocause Pharmaceutical Capital Reinvestment Ratio (2001–2023)
This chart tracks Hubei Biocause Pharmaceutical's Capital Reinvestment Ratio across 16 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Hubei Biocause Pharmaceutical.
Annual Capital Reinvestment Ratio for Hubei Biocause Pharmaceutical (2001–2023)
Year-by-year Capital Reinvestment Ratio for Hubei Biocause Pharmaceutical from 2001 to 2023. See cash generation quality of Hubei Biocause Pharmaceutical to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.01x | CN¥9.53 Billion | CN¥67.53 Million | ▼ -60.5% |
| 2022 | 0.02x | CN¥7.52 Billion | CN¥135.06 Million | ▼ -73.9% |
| 2021 | 0.07x | CN¥4.17 Billion | CN¥287.13 Million | ▲ +361.4% |
| 2020 | 0.01x | CN¥21.42 Billion | CN¥319.51 Million | ▼ -40.5% |
| 2019 | 0.03x | CN¥28.60 Billion | CN¥717.10 Million | ▲ +36.8% |
| 2018 | 0.02x | CN¥14.98 Billion | CN¥274.67 Million | ▼ -99.0% |
| 2017 | 1.80x | CN¥431.58 Million | CN¥778.95 Million | ▲ +63.8% |
| 2013 | 1.10x | CN¥130.53 Million | CN¥143.80 Million | ▼ -19.6% |
| 2012 | 1.37x | CN¥93.79 Million | CN¥128.50 Million | ▼ -38.6% |
| 2011 | 2.23x | CN¥66.95 Million | CN¥149.37 Million | ▲ +438.3% |
| 2010 | 0.41x | CN¥224.58 Million | CN¥93.09 Million | ▼ -24.1% |
| 2007 | 0.55x | CN¥118.56 Million | CN¥64.76 Million | ▼ -46.2% |
| 2006 | 1.02x | CN¥128.19 Million | CN¥130.12 Million | ▲ +101.5% |
| 2005 | 0.50x | CN¥48.66 Million | CN¥24.51 Million | ▲ +10.7% |
| 2004 | 0.46x | CN¥56.07 Million | CN¥25.52 Million | ▼ -46.0% |
| 2001 | 0.84x | CN¥37.30 Million | CN¥31.47 Million | — |